FOLD · AMICUS THERAPEUTICS, INC.
$14.49
+0.00 (+0.00%)
At close · Apr 27
Market Cap
$4.55B
Shares
314.00M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$14.49
Open$14.49
Day$14.49–14.49
52W$5.51–14.50
Avg vol 30d3.0M
Short int21.9M · 7.0% float · 7.5d
Short vol73%
Last earningsMay 4, 2026
DataJan 2020–Apr 2026
Filing10-K · Feb 20
Up next
Next earnings call
Aug 6, 2026
Est · unconfirmed
· in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Feb 20, 2026
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Bearish
Fundamentals
Excellent
Quant / Vol
Moderate
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+33%
above
Price vs 50-day avg
+1%
above
RSI (14)
70
overbought
MACD trend
Negative
52-week position
100%
near high
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+60%
trailing
YTD return
+2%
this year
Relative strength
+56%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $14 › 200d $11 — 50d above 200d
Institutional flow
Distributing
32 of 297 funds reported for Jun 30 · net -3.2M sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
6.98% of float · ▲ +3.9% MoM · 7.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
297 holders — mid 3-yr range
Fundamentals
Revenue growth
+20%
Y/Y
Gross margin
89%
contracting
EPS growth
+50%
Y/Y
Free cash flow
$29.8M
Balance sheet
$178.7M
net debt
Quant / Vol
risk profile
Volatility
46%
annualized · 1-yr
Max drawdown
−27%
past year
ATR
0.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Sep 30, 2025
Combined sales
· 2028
Initiated
$1B
prior FY $634.21M
midpoint +57.7% Y/Y
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+33%
Bullish
Price vs 50-day avg
+1%
Bullish
RSI (14)
70
Bearish
MACD trend
Negative
Bearish
52-week position
100%
Bullish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $14 › 200d $11 — 50d above 200d
Institutional flow
Distributing
32 of 297 funds reported for Jun 30 · net -3.2M sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
6.98% of float · ▲ +3.9% MoM · 7.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
297 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $6
Now $14 · 100%
52-wk high $15
vs 200-day avg +33%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Non-GAAP net income non-GAAP | $31.6M | Q4 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FOLD
this stock
AMICUS THERAPEUTICS, INC.
|
$4.55B | +1.8% | +20.0% | — | 7.0% |
|
ONC
BeOne Medicines Ltd.
|
$471.01B | +7.6% | +22179.2% | 958.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.16B | +4.4% | +46.2% | 28.3 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$68.78B | -15.4% | +20.8% | 16.0 | 3.3% |
|
ARGX
Argenx SE
|
$57.44B | +9.9% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FOLD | +0.3% | +0.6% | +60.5% | +0.2% | +1.8% |
| SPY | +1.0% | +12.8% | +4.9% | +10.0% | +4.9% |
| vs SPY | -0.8% | -12.2% | +55.6% | -9.8% | -3.1% |